| Simple multiplex RT-PCR for identifying common fusion BCR-ABL transcript types and evaluation of molecular response of the a2b2 and a2b3 transcripts to Imatinib resistance in … R Mir, I Ahmad, J Javid, M Zuberi, P Yadav, R Shazia, M Masroor, S Guru, ... Indian journal of cancer 52 (3), 314-318, 2015 | 33 | 2015 |
| Evidence of the presence of SARS‐CoV‐2 virus in atmospheric air and surfaces of a dedicated COVID hospital A Dubey, G Kotnala, TK Mandal, SC Sonkar, VK Singh, SA Guru, ... Journal of Medical Virology 93 (9), 5339-5349, 2021 | 26 | 2021 |
| The promising signatures of circulating microRNA-145 in epithelial ovarian cancer patients M Zuberi, R Mir, I Khan, J Javid, SA Guru, M Bhat, MP Sumi, I Ahmad, ... MicroRNA 9 (1), 49-57, 2020 | 23 | 2020 |
| Association of GABAA receptor gene with epilepsy syndromes MA Bhat, SA Guru, R Mir, AA Waza, M Zuberi, MP Sumi, S Bodeliwala, ... Journal of Molecular Neuroscience 65, 141-153, 2018 | 18 | 2018 |
| RASSF1 and PTEN promoter hypermethylation influences the outcome in epithelial ovarian cancer M Zuberi, R Mir, S Dholariya, I Najar, P Yadav, J Javid, S Guru, M Mirza, ... Clinical Ovarian and Other Gynecologic Cancer 7 (1-2), 33-39, 2014 | 18 | 2014 |
| miR-486-5p: a prognostic biomarker for chronic myeloid leukemia A Suchiita, SA Guru, P Yadav, M Masroor, A Samadhiya, N Bhutani, ... ACS omega 6 (11), 7711-7718, 2021 | 16 | 2021 |
| Efficacy and safety of filgrastim and its biosimilars to prevent febrile neutropenia in cancer patients: a prospective study and meta-analysis S Rastogi, V Kalaiselvan, S Ali, A Ahmad, SA Guru, M Sarwat Biology 10 (10), 1069, 2021 | 15 | 2021 |
| Ectopic PD-L1 expression in JAK2 (V617F) myeloproliferative neoplasm patients is mediated via increased activation of STAT3 and STAT5 SA Guru, MP Sumi, R Mir, AA Waza, MA Bhat, M Zuberi, P Lali, A Saxena Human cell 33, 1099-1111, 2020 | 14 | 2020 |
| microRNA-21 expression as prognostic and therapeutic response marker in chronic myeloid leukaemia patients MAB Mirza, SA Guru, SM Abdullah, A Rizvi, A Saxena Asian Pacific Journal of Cancer Prevention: APJCP 20 (8), 2379, 2019 | 12 | 2019 |
| Role of SCN1A and SCN2A gene polymorphisms in epilepsy syndromes-A study from India MA Bhat, SA Guru, R Mir, AA Waza, M Zuberi, M Sumi, S Bodeliwala, ... J Neurol Neurosci 9 (1), 238, 2018 | 10 | 2018 |
| Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib … SA Guru, MP Sumi, R Mir, MMA Beg, BC Koner, A Saxena BMC cancer 22 (1), 405, 2022 | 8 | 2022 |
| Clinical Importance of Estrogen Receptor 1 (ESR1) Gene Polymorphisms and Their Expression Patterns in Coronary Artery Disease Patients: A Study from India MP Sumi, SA Guru, R Mir, M Masroor, MA Bhat, MP Girish, A Saxena Indian Journal of Clinical Biochemistry 34, 133-142, 2019 | 8 | 2019 |
| Transplanted allogeneic cardiac progenitor cells secrete GDF-15 and stimulate an active immune remodeling process in the ischemic myocardium R Mishra, P Saha, SR Datla, P Mellacheruvu, M Gunasekaran, SA Guru, ... Journal of translational medicine 20 (1), 323, 2022 | 7 | 2022 |
| Polymorphism T81C in H-RAS oncogene is associated with disease progression in imatinib (TKI) treated chronic myeloid leukemia patients R Mir, I Ah, J Javid, M Zuberi, S Guru, M Mirza, S Farooq, P Yadav, ... World journal of oncology 6 (2), 321, 2015 | 7 | 2015 |
| Biological and clinical implications of exon 8 P53 (R282W) gene mutation in relation to development and progression of chronic myeloid leukaemia patients in India population R Mir, M Zuberi, I Ahmad, J Javid, P Yadav, S Farooq, M Masroor, S Guru, ... J Cell Sci Ther 4 (2), 2013 | 6 | 2013 |
| Quercitrin neutralizes sPLA2IIa activity, reduces the inflammatory IL-6 level in PC3 cell lines, and exhibits anti-tumor activity in the EAC-bearing mice model P Sophiya, D Urs, J K. Lone, AS Giresha, H Krishna Ram, JG Manjunatha, ... Frontiers in Pharmacology 13, 996285, 2022 | 5 | 2022 |
| GSTT1 null and rs156697 Polymorphism in GSTO2 Influence the Risk and Therapeutic Outcome of B-Acute Lymphoblastic Leukemia Patients SM Baba, AA Pandith, ZA Shah, SA Geelani, JR Bhat, A Gul, SA Guru, ... Frontiers in oncology 11, 714421, 2021 | 5 | 2021 |
| Regulation of miR-126 and miR-122 expression and response of imatinib treatment on its expression in chronic myeloid leukemia patients MM Ali Beg, SA Guru, SM Abdullah, I Ahmad, A Rizvi, J Akhter, Y Goyal, ... Oncology Research and Treatment 44 (10), 530-537, 2021 | 5 | 2021 |
| PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India SA Guru, R Mir, M Bhat, I Najar, M Zuberi, M Sumi, M Masroor, N Gupta, ... Tumor Biology 39 (10), 1010428317713857, 2017 | 5 | 2017 |
| A deletion polymorphism in the RIZ gene is associated with increased progression of imatinib treated chronic myeloid leukemia patients R Mir, IA Najar, S Guru, J Javaid, P Yadav, M Masroor, M Zuberi, S Farooq, ... Leukemia & Lymphoma 58 (7), 1694-1701, 2017 | 4 | 2017 |
Dr Rashid MirDepartment of Medical Lab Technology, Prince Fahd Bin Sultan Research chair Faculty of Applied Medical Sciences ,,University of Tabuk, Kingdom of Saudi Arabia,Verified email at ut.edu.sa
